KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Long-Term Investments: 2014-2025

Historic Long-Term Investments for Jazz Pharmaceuticals (JAZZ) over the last 8 years, with Sep 2025 value amounting to $720.0 million.

  • Jazz Pharmaceuticals' Long-Term Investments rose 80.00% to $720.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $720.0 million, marking a year-over-year increase of 80.00%. This contributed to the annual value of $580.0 million for FY2024, which is 383.33% up from last year.
  • As of Q3 2025, Jazz Pharmaceuticals' Long-Term Investments stood at $720.0 million, which was up 50.00% from $480.0 million recorded in Q2 2025.
  • Jazz Pharmaceuticals' 5-year Long-Term Investments high stood at $720.0 million for Q3 2025, and its period low was $60.0 million during Q2 2022.
  • Its 3-year average for Long-Term Investments is $434.0 million, with a median of $440.0 million in 2024.
  • As far as peak fluctuations go, Jazz Pharmaceuticals' Long-Term Investments surged by 681.25% in 2024, and later declined by 23.20% in 2025.
  • Over the past 5 years, Jazz Pharmaceuticals' Long-Term Investments (Quarterly) stood at $335.0 million in 2021, then reached $60.0 million in 2022, then skyrocketed by 316.67% to $120.0 million in 2023, then soared by 383.33% to $580.0 million in 2024, then soared by 80.00% to $720.0 million in 2025.
  • Its Long-Term Investments was $720.0 million in Q3 2025, compared to $480.0 million in Q2 2025 and $710.0 million in Q1 2025.